1. Short title This Act may be cited as the United States-Israel Common Defense Authorization Act . 2. Findings Congress finds the following: (1) There are numerous provisions in the Joint Comprehensive Plan of Action that will expire over the next decade, including the following: (A) By 2025, limitations on the number of IR–1 cascade configurations, as well as restrictions on Uranium testing with older centrifuge models IR–4, 5, 6, and 8, will be lifted. (B) By 2026, the cap on 5,060 IR–1 centrifuges at Iran’s Natanz facility, as well as the prohibition on replacing IR–1 centrifuges with more advanced models, will expire. (C) After 15 years, the ban on building heavy water reactors and a reprocessing plant becomes voluntary . (2) Although Iran will remain subject to the restrictions contained in the Additional Protocol to the Treaty on the Non-Proliferation of Nuclear Weapons, there are concerns that Iran’s breakout time could be accelerated as a result of the expiration of several provisions of the Joint Comprehensive Plan of Action. 3. Sense of Congress It is the sense of Congress that the United States should— (1) seek to extend the provisions in the Joint Comprehensive Plan of Action described in subparagraphs (A), (B), and (C) of section 2(1), including through engagement in multilateral diplomatic initiatives, without abrogating the Joint Comprehensive Plan of Action; (2) ensure that Israel and other allies are prepared for all contingencies should Iran pursue development of a nuclear weapon after expiration of provisions in the Joint Comprehensive Plan of Action described in subparagraphs (A), (B), and (C) of paragraph (1)